"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A study looking at a walking programme for people who have cancer that has come back or spread to another part of the body (CanWalk)
This study looked at whether regular walking helped to improve how people with cancer felt physically and emotionally.
It was for people who had a cancer that came back (recurrent cancer) or had spread to another part of their body (metastatic cancer).
This study was open between April and November 2014.
These results were published in 2017.
More about this trial
- if community based walking programmes were acceptable to people with cancer that came back or had spread
- whether a walking programme improved how people felt physically and emotionally
Summary of results
The study team found that the walking programme was acceptable.
About this study
This was a feasibility study. 42 people joined the study.
It was a randomised study. The people who took part were put into 1 of 2 groups. Neither they nor their doctor chose which group they were in.
21 people were in the group that did the CanWalk programme.
21 people continued with their usual levels of activity. This was the
- encourage them to join a weekly walk group from the Walking for Health (WfH) programme
- encourage them to walk in between their weekly walk with WfH
- 6 weeks
- 12 weeks
- 24 weeks (end of the study)
- what they thought about the study
- what they thought about being put into different groups (randomisation process)
- their thoughts about the questionnaires and filling them in
- 12 people (28%) between the start of the study and week 6
- 7 people (17%) between week 12 and week 24
- a preference for doing their own walks
- a dislike of group activities
- convenience and availability of the WfH walks
- emotionally and psychologically
- by changing their life style
- using another way to measure walking behaviour other than the pedometer
- using questionnaires that ask questions about social contacts
- having other groups for comparison such as a group that receives written information only
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jo Armes
Dimbleby Cancer Care
King's College London
NIHR Clinical Research Network: Cancer